MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-26-2026
Thermo Fisher Scientific Historical Prices 2011-2026 | TMO
Annual Historical Prices Thermo Fisher Scientific
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 520 | 539 | 560 | 551 | 544 | 449 | 289 | 258 | 206 | 155 | 127 | 127 | 121 | 71.2 | 54.2 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 560 | 54.2 | 305 |
Historical Prices of other stocks in the Diagnostics research industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
0.38 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
0.84 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Bioventus
BVS
|
9.12 | $ 8.96 | 0.96 % | $ 597 M |  USA |
 |
Aspira Women's Health
AWH
|
0.39 | - | -6.19 % | $ 10.5 M | USA |
 |
Brainsway Ltd.
BWAY
|
8.85 | $ 13.69 | 0.29 % | $ 99.4 M |  Israel |
 |
Castle Biosciences
CSTL
|
25.5 | $ 25.72 | -0.43 % | $ 714 M | USA |
 |
DexCom
DXCM
|
65.4 | $ 67.65 | 1.97 % | $ 26.4 B | USA |
 |
Charles River Laboratories International
CRL
|
155 | $ 153.73 | 1.16 % | $ 7.62 B | USA |
 |
CareDx, Inc
CDNA
|
18.6 | $ 17.51 | 1.1 % | $ 933 M | USA |
 |
Guardant Health
GH
|
107 | $ 88.71 | 1.75 % | $ 11.1 B | USA |
 |
Accelerate Diagnostics
AXDX
|
0.49 | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
103 | $ 103.89 | 0.04 % | $ 19.6 B | USA |
 |
Global Cord Blood Corporation
CO
|
2.5 | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
1.44 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
0.87 | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
15.4 | $ 15.47 | 3.48 % | $ 468 M | USA |
|
Biodesix
BDSX
|
0.71 | $ 16.58 | -4.11 % | $ 2.15 B | USA |
 |
ICON Public Limited Company
ICLR
|
201 | $ 99.84 | 2.28 % | $ 8.24 B |  Irlanda |
 |
Anixa Biosciences
ANIX
|
3.19 | $ 2.89 | 1.76 % | $ 93.8 K | USA |
 |
IQVIA Holdings
IQV
|
165 | $ 168.66 | 2.34 % | $ 29 B | USA |
 |
Danaher Corporation
DHR
|
210 | $ 194.7 | 1.73 % | $ 139 B | USA |
 |
Biocept
BIOC
|
0.35 | - | -13.05 % | $ 7.29 M | USA |
 |
Heska Corporation
HSKA
|
81.6 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
3.36 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
103 | $ 121.25 | 1.65 % | $ 19.3 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
210 | $ 198.2 | -0.38 % | $ 22 B | USA |
 |
QIAGEN N.V.
QGEN
|
38.3 | - | - | $ 10.6 B |  Niderland |
 |
Agilent Technologies
A
|
139 | $ 113.1 | 1.14 % | $ 34.4 B | USA |
 |
BioNano Genomics
BNGO
|
2.79 | $ 1.12 | 0.9 % | $ 1.42 M | USA |
 |
DarioHealth Corp.
DRIO
|
1.53 | $ 9.0 | 6.89 % | $ 255 M | Israel |
 |
NeoGenomics
NEO
|
11.6 | $ 8.26 | 0.18 % | $ 1.06 B | USA |
 |
Neogen Corporation
NEOG
|
4.7 | $ 9.24 | 1.37 % | $ 2 B | USA |
 |
Lantheus Holdings
LNTH
|
75.9 | $ 80.34 | 2.34 % | $ 5.42 B | USA |
 |
Pacific Biosciences of California
PACB
|
1.66 | $ 1.4 | 2.94 % | $ 420 M | USA |
 |
Chembio Diagnostics
CEMI
|
0.39 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
0.74 | - | - | $ 9.42 M | Israel |
 |
Co-Diagnostics
CODX
|
1.19 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Medpace Holdings
MEDP
|
449 | $ 454.76 | 0.25 % | $ 13.1 B | USA |
 |
Motus GI Holdings
MOTS
|
0.64 | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
1.38 K | $ 1 207.42 | 0.69 % | $ 24.9 B |  Schweiz |
 |
Celcuity
CELC
|
10.1 | $ 114.34 | -0.49 % | $ 4.51 B | USA |
 |
DermTech
DMTK
|
1.3 | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
14.1 | $ 17.76 | 2.04 % | $ 398 M | USA |
 |
Invitae Corporation
NVTA
|
2.17 | - | - | $ 21.2 M | USA |
 |
Enzo Biochem
ENZ
|
1.13 | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
53.9 | $ 198.56 | 0.45 % | $ 19.5 B | USA |
 |
OPKO Health
OPK
|
1.75 | $ 1.2 | 0.42 % | $ 833 M | USA |